[Letter: Combination of a dopa decarboxylase inhibitor with 5-hydroxytryptophan therapy].
D006916:5-Hydroxytryptophan / Q000378:metabolism / Q000627:therapeutic use*; D000328:Adult; D065105:Aromatic Amino Acid Decarboxylase Inhibitors; D004296:Dopa Decarboxylase / Q000008:administration & dosage; D004357:Drug Synergism; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009207:Myoclonus / Q000188:drug therapy*
D065105:Aromatic Amino Acid Decarboxylase Inhibitors; D006916:5-Hydroxytryptophan; D004296:Dopa Decarboxylase
Lettre: Association d'un inhibiteur de la dopadécarboxylase aux traitements par le 5-hydroxytryptophane